1

Asset Strategy Jobs (NOW HIRING)

Asset Strategy Development Leads the department's efforts to develop, refresh, and refine asset replacement, spares, testing, inspection, and maintenance strategies for assigned T&D overhead ...

Asset Reliabiity Manager

Corpus Christi, TX · On-site

$132.37 - $206.83/hr

Asset Strategy & Lifecycle Management - Develop and execute long‑term reliability strategies (3‑year reliability improvement plan and 5‑year asset strategy); establish asset lifecycle plans ...

New

Showing results 21-40

Asset Strategy information

See salary details

$35.5K

$94.1K

$164.5K

How much do asset strategy jobs pay per year?

As of Aug 21, 2026, the average yearly pay for asset strategy in the United States is $94,129.00, according to ZipRecruiter salary data. Most workers in this role earn between $74,500.00 and $109,000.00 per year, depending on experience, location, and employer.

What is an asset strategy professional?

An Asset Strategy professional is responsible for developing and implementing strategies to optimize the performance, value, and lifecycle of a company's physical or financial assets. This role involves analyzing data, assessing risks, and making recommendations to maximize returns and minimize costs. They work closely with operations, maintenance, and financial teams to ensure assets are effectively managed and aligned with the organization's overall objectives.

How does an asset strategy professional typically collaborate with other departments to optimize asset performance?

Asset Strategy professionals work closely with teams across operations, maintenance, finance, and engineering to develop and implement effective asset management plans. They often facilitate regular meetings to align on asset health, risk assessments, and lifecycle planning. Collaboration ensures that data-driven decisions support both short-term performance and long-term value, while also enabling seamless communication regarding asset priorities and investment needs. This cross-functional teamwork is vital for proactively addressing issues and driving continuous improvement in asset utilization.

What are the key skills and qualifications needed to thrive as an asset strategy professional, and why are they important?

To thrive as an Asset Strategy professional, you need strong analytical skills, an understanding of financial markets, and typically a degree in finance, economics, or a related field. Familiarity with portfolio management software, financial modeling tools, and certifications such as CFA or FRM are commonly required. Strategic thinking, attention to detail, and effective communication set standout professionals apart in this role. These skills and qualities ensure informed investment decisions, risk mitigation, and alignment of asset management with organizational goals.

What is the difference between Asset Strategy vs Asset Management?

AspectAsset StrategyAsset Management
FocusDeveloping long-term plans for asset utilization and optimizationOperational oversight and maintenance of assets
CredentialsStrategic planning, certifications in asset management or engineeringTechnical skills, certifications in asset management or operations
Work EnvironmentStrategic planning teams, corporate officesField operations, maintenance facilities
Industry UsageUsed in industries like energy, manufacturing, infrastructureApplied across similar industries for daily asset operations

Asset Strategy focuses on planning and optimizing assets for future performance, while Asset Management involves the ongoing operational management and maintenance of assets. Both roles are essential but differ in scope and objectives, with Asset Strategy being more forward-looking and Asset Management more execution-oriented.

More about Asset Strategy jobs

What cities are hiring for Asset Strategy jobs?

Cities with the most Asset Strategy job openings:

Infographic showing various Asset Strategy job openings in the United States as of August 2026, with employment types broken down into 92% Full Time, 6% Part Time, and 2% Contract. Highlights an 79% Physical, 6% Hybrid, and 15% Remote job distribution, with an average salary of $94,129 per year, or $45.3 per hour.

Vice President, Asset Strategy Lead

Syndax Pharmaceuticals

New York, NY • On-site

Full-time

Posted 10 days ago


Job description

Syndax Pharmaceuticals is looking for a Vice President, Asset Strategy Lead, Revumenib
At Syndax, we are determined to realize a future in which people with cancer live longer and better than ever before. Syndax Pharmaceuticals is a commercial stage biopharmaceutical company developing an innovative pipeline of cancer therapies.
The Role:
The Asset Strategy Lead (ASL), Late Development provides leadership to a cross-functional strategic asset team and leads the development and execution of the asset strategy. Further, the ASL champions the product/brand at all levels of Syndax and is responsible for managing the alignment on communication on all Asset Strategy Team (AST) matters, as appropriate.
We are seeking a Vice President, Asset Strategy Lead, Late Development. This individual will bring a demonstrated record of strategic leadership and operational excellence in global oncology product development, with experience leading late-stage programs through regulatory approval and commercialization.
This role will be a key member of the Syndax's senior leadership team, influencing portfolio strategy and execution. The ideal candidate will lead the asset with a long-term enterprise view, integrating scientific, clinical, regulatory, commercial, and financial perspectives to optimize asset value.
Key Responsibilities:
  • Provide strategic leadership for a late-stage, commercially approved asset with an ongoing Phase 3 program, ensuring seamless integration across clinical development, regulatory, and commercial lifecycle priorities.
  • Lead the design and execution of a differentiated external strategy, with a strong focus on investigator-sponsored research (ISR), peer-to-peer scientific engagement, and academic collaboration to expand the evidence base and reinforce clinical value.
  • Build and sustain high-impact relationships with key investigators, institutions, and thought leaders, positioning the asset and the company as a trusted, scientifically credible partner in the field.
  • Serve as a visible external ambassador for the program and the organization at scientific congresses, advisory boards, and strategic forums, actively shaping the narrative and strengthening brand awareness and reputation.
  • Identifies potential issues and leads contingency planning; leads AST problem solving and applies decision-making tools and techniques. Drives AST to make effective and efficient decisions.
  • Serve as a key liaison to the Executive Leadership Team, providing updates, insights, and recommendations that inform enterprise decisions.
  • Lead long-range planning, including scenario planning, investment strategy, and external innovation assessments related to the asset.
  • Partner with Commercial, Medical Affairs, Regulatory, and Development to shape Target Product Profile (TPP) and ensure robust lifecycle and global expansion planning.
  • Leads resolution of conflict at the AST and oversees governance engagement, ensuring timely and transparent communication on key decisions, risks, budgets, and timelines.
  • Foster a culture of accountability, innovation, and excellence, modeling strong leadership and collaborative behaviors.
  • Represent Syndax in strategic partnerships, collaborations, and scientific/medical forums as appropriate.

Desired Experience/Education and Personal Attributes:
  • Educational Requirements: Advanced degree in life sciences, medicine, or business (e.g., PhD, MD, MBA) highly preferred.
  • A minimum of 10 or more years of experience in late-stage development, ideally including an approved asset and active Phase 3 or lifecycle expansion programs Demonstrated track record of operating at the intersection of development, medical affairs, and commercial functions, with direct experience in at least one of these areas (Medical Affairs, Commercial, or Market Access) strongly preferred.
  • Strong business acumen with the ability to evaluate clinical strategy through a commercial lens, including understanding of market dynamics, competitive positioning, and value proposition development.
  • Experience translating scientific and clinical data into differentiated product narratives that support launch excellence, lifecycle growth, and external brand building in a competitive therapeutic area.
  • Proven ability to partner with Commercial and Medical Affairs teams to shape Target Product Profiles (TPP), inform positioning strategy, and align evidence generation with market needs.
  • Deep understanding of late-stage and post-approval evidence generation strategies, including investigator-sponsored research (ISR), real-world evidence (RWE), and publication planning, with a focus on driving scientific influence and external credibility.
  • Prior experience interacting with C-suite executives, external partners, and regulators.
  • Highly collaborative, with strong influencing skills and ability to work across multiple levels and functions.
  • Executive presence and outstanding communication skills, including comfort presenting to senior and external audiences.
  • Experience with portfolio management, financial modeling, and program valuation is highly desirable.

Location: Syndax's corporate office is in New York, NY.
Syndax offers a total compensation and rewards package that is among the most competitive in the industry. Base pay is just one element of our package and is determined within a range based on several factors including market data, experience, qualifications, demonstrated skills, relevant education or training, travel requirements and internal equity. Our overall package also includes an equity offering, annual target bonuses, and an outstanding benefits program. The anticipated annualized salary range for this role is $380,000 - $420,000.
About Syndax:
Syndax Pharmaceuticals is a commercial-stage biopharmaceutical company advancing innovative cancer therapies. Highlights of the Company's pipeline include a menin inhibitor for R/R acute leukemia and a monoclonal antibody that blocks the CSF-1 receptor for chronic graft-versus-host disease. Fueled by our commitment to reimagining cancer care, Syndax is working to unlock the full potential of its pipeline and is conducting several clinical trials across the continuum of treatment. For more information, please visit www.syndax.com/ or follow the Company on X and LinkedIn.
Syndax Pharmaceuticals is an equal opportunity employer and will not discriminate against any employee or applicant on the basis of age, color, disability, gender, national origin, race, religion, sexual orientation, veteran status, or any classification protected by federal, state, or local law.